What is Canton Strategic Holdings, Inc.'s (CNTN) StockRank?

MoatMap's StockRank for Canton Strategic Holdings, Inc. (CNTN) is 8/100, with a Strong Sell signal. This is a composite score combining Quality (35), Value (34), and Momentum (11) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Canton Strategic Holdings, Inc. have an economic moat?

Canton Strategic Holdings, Inc. (CNTN) has a Quality factor score of 35/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Canton Strategic Holdings, Inc. a buy, hold, or sell?

MoatMap's current signal for Canton Strategic Holdings, Inc. (CNTN) is Strong Sell, based on a StockRank of 8/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Canton Strategic Holdings, Inc. in?

Canton Strategic Holdings, Inc. (CNTN) operates in the Healthcare sector, specifically the Biotechnology industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

CNTN

Strong SellSinker

Canton Strategic Holdings, Inc. · Healthcare · United States · $177M · Avg Vol: $1M/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

-42.2%

D/E

0.0x

Dividend %

—

COMPANY DESCRIPTION

Canton Strategic Holdings is a holding company actively seeking to acquire and develop businesses, with a stated focus on opportunities within the healthcare sector. Operating as an investment vehicle, it aims to build a diversified portfolio through strategic mergers and acquisitions. The company's future growth is dependent on its ability to successfully identify and integrate target businesses.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	2025	CAGR	TTM
Revenue	—	0	0	0	0	—	—
EPS	—	-0.11	-1.09	-0.24	-0.54	—	-0.15
Shares	—	77.1M	77.1M	77.1M	77.1M	0.0%	79.7M
Debt	2.2M	—	—	—	—	—	—
Equity	—	5.5M	9.1M	1.3M	397.9M	315.6%	—
Op CF	—	-6.6M	-7.3M	-10.9M	-16.1M	—	-22.2M
Inv CF	—	0	0	0	-77.6M	—	—
Fin CF	—	13.1M	11.7M	3.5M	107.2M	—	—

Loading 1Y...

PRICE (1Y)+16.2%

SMA 50SMA 200

$2.15

RSI (14)

47.4

52W High

$6.89

From 52W High

0.3%

SCORE BREAKDOWN

Quality

ROIC

-17.7%30.6

ROE

-42.2%20.7

GP/Assets

0.3%11.0

Op. Margin

-80.4%18.2

FCF/Assets

-18.0%22.4

Piotroski

457.9

Int. Cover

-50.0x5.9

D/E Ratio

0.00x98.1

Current Ratio

15.70x93.5

Value

P/E (TTM)

—N/A

EV/EBITDA

—N/A

P/FCF

—N/A

P/B

0.4x98.3

P/S

121.5x6.3

Div Yield

—N/A

Momentum

52W High %

31%8.2

RS 6M

-66%6.2

SMA 50/200

0.71x8.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$177M

P/E (Forward)

—

Gross Margin

100.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CNTN are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
CNTN	Canton Strategic Holdings, Inc.(you)	$177M	8	Strong Sell
KPTI	Karyopharm Therapeutics Inc.	$168M	11	Strong Sell
CRBP	Corbus Pharmaceuticals Holdings, Inc.	$211M	7	Strong Sell
NBP	NovaBridge Biosciences	$213M	10	Strong Sell
SPRB	Spruce Biosciences, Inc.	$175M	13	Strong Sell
TARA	Protara Therapeutics, Inc.	$226M	9	Strong Sell
CNTB	Connect Biopharma Holdings Limited	$140M	10	Strong Sell
LENZ	LENZ Therapeutics, Inc.	$161M	14	Strong Sell
HUMA	Humacyte, Inc.	$181M	2	Strong Sell
INDP	Indaptus Therapeutics, Inc.	$152M	13	Strong Sell

Peer medians: ROE -30.2% · P/E 27.0x · Gross margin 58.1%

Canton Strategic Holdings, Inc. (CNTN): Stock Score Summary

Canton Strategic Holdings, Inc. (CNTN) has a MoatMap StockRank of 8/100 based on Quality (35/100), Value (34/100), and Momentum (11/100) factor scores. The current signal is STRONG SELL.

Key Financial Metrics

Price	$2.15
Market Cap	$177M
Price/Book	0.39
Return on Equity	-42.2%
Return on Invested Capital	-17.7%
Debt/Equity	0.00x
Gross Margin	100.0%
Operating Margin	-80.4%
Free Cash Flow	$-94M

Canton Strategic Holdings, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Canton Strategic Holdings, Inc.’s (CNTN) StockRank?: MoatMap’s StockRank for Canton Strategic Holdings, Inc. (CNTN) is 8/100, with a Strong Sell signal. It is a composite of Quality (35), Value (34), and Momentum (11) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Canton Strategic Holdings, Inc. have an economic moat?: Canton Strategic Holdings, Inc. (CNTN) has a Quality factor score of 35/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Canton Strategic Holdings, Inc. a buy, hold, or sell?: MoatMap’s current signal for Canton Strategic Holdings, Inc. (CNTN) is Strong Sell, based on a StockRank of 8/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Canton Strategic Holdings, Inc. in?: Canton Strategic Holdings, Inc. (CNTN) operates in the Healthcare sector, specifically the Biotechnology industry (United States).